Literature DB >> 27136262

Optimization of Perioperative Conditions to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Donor Liver Transplantation.

Chandrashekhar Kubal1, Richard Mangus, Jonathan Fridell, Romil Saxena, Natalia Rush, Matthew Wingler, Burcin Ekser, Joseph Tector.   

Abstract

BACKGROUND: Donation after circulatory death (DCD) donor pool remains underutilized for liver transplantation (LT). We describe optimizing "modifiable risk factors," such as cold ischemia time (CIT) recipient warm ischemia time (WIT) and the use of thrombolytic flush at the time of procurement to minimize ischemic cholangiopathy (IC).
METHODS: From July 2011 (era II), to improve outcomes after DCD LT, measures were taken to minimize CIT, operative time and recipient WIT along with the use of tissue plasminogen activator (tPA) flush during DCD procurements. Thirty consecutive DCD LTs were performed prospectively in era II. Outcomes were compared with 61 historic controls (era I). Reperfusion biopsies were evaluated for the presence of necrosis and biliary epithelial damage.
RESULTS: Median CIT (4.9 [3.5-5.9] vs 6.4 [4.3-12]; P < 0.001), hepatectomy time (70 [42-120] vs 81 [58-207]; P = 0.02), and recipient WIT (16 [13-31] vs 24[15-40]; P < 0.001) were significantly shorter in era II. All patients in era II received tPA flushed liver grafts. None of the patients in era II developed IC (0% vs 18%; P = 0.013). There were fewer biliary complications in era II, and there was no increased risk of bleeding associated with the use of tPA. One-year graft survival was slightly better in era II (n = 24 patients with 1 year follow-up) (88% vs 80%; P = 0.14).
CONCLUSIONS: Optimizing peritransplant conditions, such as shortening ischemic times with the use of thrombolytic donor flush, may prevent IC after DCD LT. With this approach, the DCD donor pool may be expanded.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27136262     DOI: 10.1097/TP.0000000000001204

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

Review 1.  Addressing organ shortages: progress in donation after circulatory death for liver transplantation

Authors:  Jordan J. Nostedt; James Shapiro; Darren H. Freed; David L. Bigam
Journal:  Can J Surg       Date:  2020-03-20       Impact factor: 2.089

2.  Risk factors of acute kidney injury after orthotopic liver transplantation in China.

Authors:  Yin Zongyi; Li Baifeng; Zou Funian; Li Hao; Wang Xin
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

3.  Donation after circulatory death liver transplantation: consensus statements from the Spanish Liver Transplantation Society.

Authors:  Amelia J Hessheimer; Mikel Gastaca; Eduardo Miñambres; Jordi Colmenero; Constantino Fondevila
Journal:  Transpl Int       Date:  2020-05-15       Impact factor: 3.782

Review 4.  Systematic Review and Meta-Analysis on the Impact of Thrombolytic Therapy in Liver Transplantation Following Donation after Circulatory Death.

Authors:  Kumar Jayant; Isabella Reccia; Francesco Virdis; A M James Shapiro
Journal:  J Clin Med       Date:  2018-11-08       Impact factor: 4.241

5.  Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain.

Authors:  Daiki Soma; Yujin Park; Plamen Mihaylov; Burcin Ekser; Marwan Ghabril; Marco Lacerda; Naga Chalasani; Richard S Mangus; Chandrashekhar A Kubal
Journal:  Transplant Direct       Date:  2022-01-05

6.  Thrombolytic Therapy During ex-vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury.

Authors:  Omar Haque; Siavash Raigani; Ivy Rosales; Cailah Carroll; Taylor M Coe; Sofia Baptista; Heidi Yeh; Korkut Uygun; Francis L Delmonico; James F Markmann
Journal:  Front Surg       Date:  2021-06-17

7.  Impact of Donor Pre-Procurement Cardiac Arrest (PPCA) on Clinical Outcomes in Liver Transplantation.

Authors:  Richard S Mangus; Joel R Schroering; Jonathan A Fridell; Chandrashekhar A Kubal
Journal:  Ann Transplant       Date:  2018-11-20       Impact factor: 1.530

8.  Impact of Recipient Age in Combined Liver-Kidney Transplantation: Caution Is Needed for Patients ≥70 Years.

Authors:  Burcin Ekser; William C Goggins; Jonathan A Fridell; Plamen Mihaylov; Richard S Mangus; Andrew J Lutz; Daiki Soma; Marwan S Ghabril; Marco A Lacerda; John A Powelson; Chandrashekhar A Kubal
Journal:  Transplant Direct       Date:  2020-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.